Skip to main content

Advertisement

Fig. 3 | Journal of Translational Medicine

Fig. 3

From: High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome

Fig. 3

Comparison of overall survival of patients with high and low hENT1 expression treated with decitabine. a In all MDS patients, the median overall survival time was not significantly different between high hENT1 patients and low hENT1 patients. b In the higher-risk patients, a prolonged overall survival time was observed in patients with high hENT1 compared to those with low hENT1

Back to article page